Aurobindo Pharma buys Sandoz's US business in $900 million deal

The deal gives the Hyderabad based company access to Sandoz's portfolio of oral solids and dermatology drugs and manufacturing footprint

from Latest News https://ift.tt/2PFYVf2
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share